| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 | Jun 7, 2022 | Aprea Therapeutics, Inc. | CEO | Sell | 42.5 | -65,770 | -21.66% | ✗ | $52.9K |
| May 18, 2022 | May 19, 2022 | Aprea Therapeutics, Inc. | CEO | Buy | 91.3 | +37,500 | 14.09% | ✗ | $24.1K |
| Feb 25, 2022 | Mar 1, 2022 | Aprea Therapeutics, Inc. | CEO | Sell | 46.3 | -21,644 | -11.53% | ✗ | $37.7K |
| Oct 7, 2019 | Oct 7, 2019 | Aprea Therapeutics, Inc. | CEO | Buy | 95.0 | +11,000 | 6875.00% | ✗ | $165K |
| May 10, 2019 | May 14, 2019 | INTEGRA LIFESCIENCES HOLDINGS CORP | Director | Sell | 20.0 | -15,658 | -32.42% | ✗ | $807.3K |
| Mar 5, 2018 | Mar 6, 2018 | INTEGRA LIFESCIENCES HOLDINGS CORP | Director | Sell | 20.0 | -15,658 | -34.55% | ✗ | $828K |
| May 3, 2016 | May 5, 2016 | INTEGRA LIFESCIENCES HOLDINGS CORP | Director | Sell | 20.0 | -7,829 | -42.20% | ✗ | $551.3K |